Evidence map›Paper›PMID 35207097›Full record

ReviewMembranes2022

Artificial Kidney Engineering: The Development of Dialysis Membranes for Blood Purification.

Yu-Shuo Tang, Yu-Cheng Tsai, Tzen-Wen Chen, Szu-Yuan Li

Abstract readReview
In one paragraph

Review in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Correlation between real sieving coefficient determined using novel lab-scale module and pore structure of hemodiafiltration membranes.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. 3D porous structure imaging of membranes for medical devices using scanning probe microscopy and electron microscopy: from membrane science points of view.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu-Shuo TangDepartment of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan.
Yu-Cheng TsaiDepartment of Medical Research, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Tzen-Wen ChenDivision of Nephrology, Department of Medicine, Wei-Gong Memorial Hospital, Miaoli County 351, Taiwan.
Szu-Yuan LiDivision of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.ORCID 0000-0002-3639-8212

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The artificial kidney, one of the greatest medical inventions in the 20th century, has saved innumerable lives with end stage renal disease. Designs of artificial kidney evolved dramatically in decades of development. A hollow-fibered membrane with well controlled blood and dialysate flow became the major design of the modern artificial kidney. Although they have been well established to prolong patients' lives, the modern blood purification system is still imperfect. Patient's quality of life, complications, and lack of metabolic functions are shortcomings of current blood purification treatment. The direction of future artificial kidneys is toward miniaturization, better biocompatibility, and providing metabolic functions. Studies and trials of silicon nanopore membranes, tissue engineering for renal cell bioreactors, and dialysate regeneration are all under development to overcome the shortcomings of current artificial kidneys. With all these advancements, wearable or implantable artificial kidneys will be achievable.

Indexed as

artificial kidneycell bioreactorimplantable artificial kidneynanopore silicon membraneREDY systemwearable artificial kidney

Identifiers

PMID35207097
PMCPMC8876607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.